GXT - GeneXpert or Chest-X-ray or Tuberculin Skin Testing for Household Contact Assessment

NACompletedINTERVENTIONAL
Enrollment

1,589

Participants

Timeline

Start Date

January 31, 2020

Primary Completion Date

November 30, 2022

Study Completion Date

June 30, 2023

Conditions
Latent Tuberculosis
Interventions
OTHER

Strategy 2: Symptom screen, Genexpert and TST

Participants follow an algorithm similar to the standard care, however participants with positive symptom screen and/or positive TST will receive GX (i.e., GX replaces CXR in standard care algorithm). GX positive are considered to have active TB. TST positive and GX negative receive LTBI treatment. If an individual is not able to provide sputum, they will undergo a CXR.

OTHER

Strategy 3:Symptom screen, CXR but NO TST

Participants will receive symptom screening and CXR. No TST will be performed. If CXR abnormal or symptom positive, they undergo microbiological investigation. If the CXR is normal, and/or microbiological investigations negative - they receive LTBI treatment as per national guidelines. If microbiological investigation is positive they will be offered treatment for active TB.

Trial Locations (4)

Unknown

Centre National Hospitalier Universitaire de Pneumo Phtisiologie de Cotonou (CNHU-PPC), Cotonou

Manaus, Manaus

Porto Alegre, Porto Alegre

Centro de Estudos, Pesquisa e Desenvolvimento Tecnológico em Saúde Coletiva - CEPESC, Rio de Janeiro

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

NCT04528823 - GXT - GeneXpert or Chest-X-ray or Tuberculin Skin Testing for Household Contact Assessment | Biotech Hunter | Biotech Hunter